Mid-Year Report

INVITROGEN CORPORATION for INVITROGEN CORPORATION

Firm
Client
Income
—
Expenses
$320,000

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY08 LHHS Appropriations Bill, HR 3043, S 1710 - in favor of additional biomedical research funding FY08 Budget Resolution, H. Con. Res 99, S Con Res 21 - in favor of adding funds for health and education accounts FY08 DoD Appropriations Bill, HR 3222, -- biodefense funding, FOR

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 21 (110th), H.R. 3222 (110th), H.R. 3043 (110th), H.Con.Res. 99 (110th)

Copyright/Patent/Trademark CPT

H.R. 1908, S. 1145 Patent Reform legislation -- against inclusion of a research use exemption provision in patent reform legislation. Concerns regarding post grant opposition and apportionment of damages provisions.

LobbyistCovered position, as disclosed
JANET LYNCH LAMBERT N/A

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1908 (110th), S. 1145 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.